• Decision Drivers in Health Technology Assessment in Hepatitis C

    Nov 1, 2015, 00:00

  • Comparison between HTA Reports in Veneto and Emilia Romagna- Drugs Assessment Decision Criteria and Priorities

    Nov 1, 2015, 00:00

  • Long-Term Trends In Descriptive Epidemiology Of Malignant Melanoma In The Slovak Republic

    Nov 1, 2015, 00:00

  • Health Technology Assessment Practices In Turkey

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Rivaroxabán Como Profilaxis En Cirugía De Reemplazo Total De Cadera Y/O De Rodilla Frente A Enoxaparina, En Colombia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Nilotinib In Patients With Chronic Myeloid Leukaemia Eligible To Start The Treatment-Free Remission Phase In Italy

    Nov 1, 2015, 00:00

  • Mortality Rate and Premature Mortality Due to Systemic Erythematosus Lupus (Sle) in Latin America, Us and England and Wales

    Nov 1, 2015, 00:00

  • Methotdological Difficulties Of Compliance Analyses Based On Real-World Data

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Bladder Cancer- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Orphan Drug Regulation In The Usa, European Union, Japan and South Korea- A Comparative Analysis

    Nov 1, 2015, 00:00

  • Exhaled Nitric Oxide For The Diagnosis Of Asthma In Adults And Children- A Systematic Review

    Nov 1, 2015, 00:00

  • Development and Validation of A Patient-Reported Outcome Measure of the Psychological Impact of Submental Fat

    Nov 1, 2015, 00:00

  • Aumento del Riesgo de Cancer por Efecto de Variaciones Acumuladas en la Exposici”n a la Radiacion en Estudios de Radiología Convencional y Tomografía Computarizada en Pacientes Pediátricos

    Nov 1, 2015, 00:00

  • The United States Specialty Pharmacy Payor Landscape

    Nov 1, 2015, 00:00

  • Identifying Research Gaps in Antimicrobial Resistance (Amr)- Literature Review, Potential Research Questions and Study Designs

    Nov 1, 2015, 00:00

  • Changes In The Prices Of Reference Biotechnology Products By The Penetration Of Biosimilars Into The Turkish Pharmaceutical Market

    Nov 1, 2015, 00:00

  • Antipsychotic Exposure And Risk of Stroke- A Systematic Review And Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • Economic Evaluation of Ulipristal Acetate For The Treatment of Patients With Moderate And Severe Symptoms of Uterine Fibroids Before Surgery In Mexico

    Nov 1, 2015, 00:00

  • Measuring Post-Partum Hemorrhage In Low-Resource Settings- The Diagnostic Validity Of Weighted Blood Loss Versus Quantitative Changes In Hemoglobin

    Nov 1, 2015, 00:00

  • The Use Of Real World Evidence To Support Market Access Of Medical Devices – Implications For The German Setting

    Nov 1, 2015, 00:00

  • An Evaluation of a New Regional Decision making Process in Sweden for High-Cost Hospital Therapies

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Tiotropium For Severe Persistent Asthma In Portugal

    Nov 1, 2015, 00:00

  • The Relationship Between Socioeconomic Characteristics And Self-Rated Health In Greece

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Heart Failure Patients- Health Utilities And Predictive Determinants

    Nov 1, 2015, 00:00

  • A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

    Nov 1, 2015, 00:00

  • The Burden of Obesity in Mexico- Prevalence, Comorbidities, and Associations With Quality of Life, Resource Utilization and Productivity

    Nov 1, 2015, 00:00

  • Switching to A 6-Monthly Triptorelin Formulation for Prostate Cancer (Pca) Reduces Patient–Nhs Interactions and Hospital Resource use- Real World Evidence (Rwe) from Project Deserve (Decapeptyl Service Evaluation)

    Nov 1, 2015, 00:00

  • Does A New Pharmacoeconomic Model Is Demanded for Obesity’s Pharmacotherapy Assessment?

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Oral Chemotherapy Regimen In Metastatic Breast Cancer Egyption Prospective

    Nov 1, 2015, 00:00

  • The Indirect Costs of Inflammatory Bowel Disease (Crohn’s Disease And Ulcerative Colitis) Associated With Absenteeism In Poland In 2013

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of A Novel Pharmacist Guided Warfarin Pharmacogenetic Service

    Nov 1, 2015, 00:00

  • Meta-Analysis to Support Technology Submissions to Health Technology Assessment Authorities- Criticisms By Nice And Evidence Review Groups in the Uk

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Cetuximab In First-Line Treatment Of Patients With Metastatic Colorectal Cancer In Belgium And The Netherlands

    Nov 1, 2015, 00:00

  • A Pilot Study Measuring Knowledge and Attitudes Towards Diabetes Mellitus In Kedah, Malaysia

    Nov 1, 2015, 00:00

  • Preference Elicitation On Benefits And Risks Of Medicines Using A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • Biossimilars, Are they Really Cost Saving? The Case of Recombinant Human Follicle Stimulating Hormone in Portugal

    Nov 1, 2015, 00:00

  • Risk Factors and Causes of Intrauterine Death

    Nov 1, 2015, 00:00

  • Economic Evaluation for The Decision Making Process of Implementing of Pharmaceutical Care for The Treatment of Hypertension In The Brazilian Health System- Stage I - Direct-Costs Analysis

    Nov 1, 2015, 00:00

  • Longitudinal Changes in Medical Services Costs from 2006 to 2012 for Newly Diagnosed T2D Patients

    Nov 1, 2015, 00:00

  • Decrease of Patient Costs in the Netherlands- a Cost of Illness Study in Metastatic Non Small Cell Lung Cancer (Nsclc)

    Nov 1, 2015, 00:00

  • Ankylosing Spondylitis Treatment and Follow-Up Costs in Colombia

    Nov 1, 2015, 00:00

  • Developing A Drug Price Reference Index In The Philippines

    Nov 1, 2015, 00:00

  • Usability Testing of an Integrated Glucometer and Handheld Electronic Patient-Reported Outcome System

    Nov 1, 2015, 00:00

  • Mental Health Disorder Prevalence Trends In Germany- A Longitudinal Analysis

    Nov 1, 2015, 00:00

  • Inflation, Inflexibility and Irrelevance – the Need for Inflation to be Accounted for in Icer Thresholds

    Nov 1, 2015, 00:00

  • Opioids Switch In Chronic Pain- Impact Assessment Using Electronic Health Records

    Nov 1, 2015, 00:00

  • Comparative Efficacy And Costs Of Treatment Sequences In Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Can Advances in Health Monitors Lead to Health Being Looked at as A Commodity?

    Nov 1, 2015, 00:00

  • Regulations of The German Drug Market

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Tiotropium Administrated Through The Respimat Inhaler As Add-On Therapy In Patients With Uncontrolled Severe Asthma In Poland

    Nov 1, 2015, 00:00

  • Relationship Between Non Compliance to Claim Medication in Pharmacy and Incidence of Hospitalizations in Patients with Breast Cancer

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Model Evaluating Component-Resolved Diagnosis (Crd) Versus Standard Testing Method (Skin Prick Testing (Spt)) In The Diagnosis And Treatment of Allergic Rhinitis In The Netherlands

    Nov 1, 2015, 00:00

  • Comparison of Cost of Treatment of Selected Cancers with Patented Drugs- India Versus its Neighbors

    Nov 1, 2015, 00:00

  • Costs of Adverse Drug Events- Systematic Review

    Nov 1, 2015, 00:00

  • Resource Utilization And Treatment Costs Of Stroke In Patients With Non-Valvular Atrial Fibrillation In Spain

    Nov 1, 2015, 00:00

  • Health State Utilities Associated With Glucose Monitoring Devices

    Nov 1, 2015, 00:00

  • Cost utility analysis of spinal cord stimulation vs. Reoperation in the treatment of failed back surgery syndrome in colombia

    Nov 1, 2015, 00:00

  • Custo-Efetividade Da Cintilografia Óssea De Corpo Inteiro Na Avaliação Pre-Transplante Hepático De Pacientes Com Carcinoma Hepatocelular Na Região Sul Do Brasil

    Nov 1, 2015, 00:00

  • Associated Factors The Virologic Success In A Group of Patients With Human Immunodeficiency Virus, Managed By A Care Team Integral, Eps|Sura Medellin 2010-2013

    Nov 1, 2015, 00:00

  • Modeling The Burden of Abdominal Aortic Aneurysm (Aaa) In Europe In 2013

    Nov 1, 2015, 00:00

  • Economic and Humanistic Burden of Ductal Carcinoma in Situ

    Nov 1, 2015, 00:00

  • Field Monitoring Of The Z Benefits For Breast Cancer Of The Philippine Health Insurance Corporation

    Nov 1, 2015, 00:00

  • Physicians’ Choice As A Comparator In Clinical Trials- Challenges for Pharmacoeconomic Modelling of Innovative Treatments to Support Health Technology Assessments

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Pen Devices For Nph Insulin Administration Compared With Syringe And Vial In Adult Patients With Diabetes Mellitus In Colombia

    Nov 1, 2015, 00:00

  • Cost Implications of Further Limiting or Increasing Generic Prescribing of Antiepileptics In English And Welsh General Practices

    Nov 1, 2015, 00:00

  • How Can Biosimilars Compete with Existing Biologics- update of the Results of a Previous Study

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of Geriatric Diabetics in a Tertiary Care Hospital- A Prospective Study

    Nov 1, 2015, 00:00

  • New Possibility for Testing The Dynamic Stability of The Trunk and Lower Extremities

    Nov 1, 2015, 00:00

  • Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013

    Nov 1, 2015, 00:00

  • The Use of Mobile Health Technology in Promoting Infant Vaccine Adherence – A Health Technology Assessment

    Nov 1, 2015, 00:00

  • Comparação De Custos E Efetividade Entre Ml- Flow E Baciloscopia Para Auxílio Diagn”Stico E Tratamento Da Hanseníase

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Respiratory Medication Therapy Adherence Clinic (Rmtac) On Asthma Patients In Malaysia

    Nov 1, 2015, 00:00

  • Cost-Utility Of Ranolazine For The Symptomatic Treatment Of Patients With Chronic Angina Pectoris In Greece

    Nov 1, 2015, 00:00

  • Economic Analysis Of Epicup, An Epigenetic Test To Predict The Tissue Of Origin In Cancer Of Unknown Primary Site, From The Spanish Nhs Perspective

    Nov 1, 2015, 00:00

  • The Irish Cost-Effectiveness Threshold- Does It Support Rational Rationing or Might It Lead to Unintended Harm of Ireland’s Health System?

    Nov 1, 2015, 00:00

  • Trends in Hospital Standardized Mortality Ratios in Japan

    Nov 1, 2015, 00:00

  • Cost-Utility of Bariatric Surgery In Belgium, Denmark, and Italy

    Nov 1, 2015, 00:00

  • Cost Comparison of Oral Versus iv Vinorlbine in France in Advanced Breast Cancer

    Nov 1, 2015, 00:00

  • Reducing The Barriers To Capturing Patient Reported Outcomes In Oncology Studies

    Nov 1, 2015, 00:00

  • Cost-Minimisation Analysis of Dexmedetomidine Versus Propofol in Mechanical Ventilated Patients at Icu

    Nov 1, 2015, 00:00

  • Evaluación Económica del uso de Un Paquete de Tres Torundas de Algodón Estériles Frente a Toallas Impregnadas Con Solución Antiséptica Como Estrategia de Antisepsia en Venopunción

    Nov 1, 2015, 00:00

  • The Role of Education In The Management of Type 1 Diabetes Mellitus In England

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of A Genomic Test Compared To Standard Of Care In Breast Cancer Patients In France

    Nov 1, 2015, 00:00

  • Development Of Medical And Technological Documents On Standardization Of Medical Care In Cardiovascular Diseases In Ukraine

    Nov 1, 2015, 00:00

  • Utilizacion De Antibacterianos De Uso Restringido En Pacientes Adultos Hospitalizados En El Hospital Las Higueras - Talcahuano

    Nov 1, 2015, 00:00

  • International Differences in the Role of Payer and Administrative Controls in Prescribing Decisions

    Nov 1, 2015, 00:00

  • Machine Learning For Identifying Potentially Undiagnosed Post-Stroke Spasticity Patients In United Kingdom

    Nov 1, 2015, 00:00

  • Comparison of Pharmaceutical Pricing and Reimbursement Systems In Turkey And Certain Other Eu Countries

    Nov 1, 2015, 00:00

  • Determinant Factors of the Administrative Pathway to Access Medicines in the Brazilian Health System

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Long-Acting Insulin Analogues in the Perspective of Brazilian Public Health System

    Nov 1, 2015, 00:00

  • To Study The Clinical Characteristics, Treatment Pattern And Factors Associated With The Total Hospital Cost In Acute Respiratory Distress Syndrome In Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Using Machine Learning Techniques To Classify Oecd Countries According to Health Expenditures

    Nov 1, 2015, 00:00

  • Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Bra A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies

    Nov 1, 2015, 00:00

  • The Effect of Positioning The Lower Extremities on Postoperative Bleeding After Total Knee Replacement

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Umeclidinium/Vilanterol In Symptomatic Copd Spanish Patients

    Nov 1, 2015, 00:00

  • Cost Benefits Of Incorporating Levosimendan Into Cardiac Surgery Practi German Base Case

    Nov 1, 2015, 00:00

  • Cost-minimization analysis of the carboxymaltose ferric (i.v.) Compared with sacarato ferric (i.v.) in the treatment of anemia under suplementary health care perspective

    Nov 1, 2015, 00:00

  • The Use of Real World Data to Build Economic Models- A Case Study of Osteoporosis

    Nov 1, 2015, 00:00

  • The Association Between Tolerability Issues and Health Outcomes Among Patients with Hcv in Brazil

    Nov 1, 2015, 00:00

  • Prices of Pharmaceuticals Under a Generic Price Linkage System And a Reference Price System- Comparison of Austria and Finland

    Nov 1, 2015, 00:00

  • Indirect Comparison to Evaluate the Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors (DPP4I) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2I) Added to Insulin Therapy in Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Uso de recursos y costos relacionados al tratamiento de complicaciones de la diabetes mellitus tipo 2 (dmt2) en colombia. Una estimacion basada en guias de practica clinica (gpc)

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease

    Nov 1, 2015, 00:00

  • Barriers To Participation In Trials Of Cancer- A Survey On Clinical Research Perception

    Nov 1, 2015, 00:00

  • Representing the Threshold in the Cost-Effectiveness Plane- Proposing a New Graphical Convention

    Nov 1, 2015, 00:00

  • Cost and Cost-Effectiveness Data on Pancreatic Cancer- a Comprehensive Review of the Literature

    Nov 1, 2015, 00:00

  • Costs of Relapse of Schizophrenia for Colombian Health System

    Nov 1, 2015, 00:00

  • Long-Term Increased Inpatient and Outpatient Visits Associated with Cardiovascular Events- a Large United States Real World Study

    Nov 1, 2015, 00:00

  • Tratamiento Ambulatorio Versus Hospitalario Relacionado A Agudizaciones En Pacientes Con Asma Desde Una Perspectiva Institucional Publica Mexicana

    Nov 1, 2015, 00:00

  • Reliability of Manufacturers’ Budget Impact Estimates for Chronic Hcv Gt1 Drugs in Poland

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson’S Disease

    Nov 1, 2015, 00:00

  • The Analysis of Telemedicine Technologies In Pediatric Patients

    Nov 1, 2015, 00:00

  • There Is Evidence of Increased Risk of Cancer In Patients Using Human Insulin Analogue Glargine For Treatment of Diabetes Mellitus - Overview Based Evaluation

    Nov 1, 2015, 00:00

  • Association Between Depression And Discontinuation With Antidiabetic Drugs

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela

    Nov 1, 2015, 00:00

  • The Impact Of Pharmaceutical Innovation On Longevity In Portugal, 2002–2010

    Nov 1, 2015, 00:00

  • First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d

    Nov 1, 2015, 00:00

  • Implant Versus Oral Contraception Use- 3-Years Budget Impact Analysis for the National Heal System in Portugal

    Nov 1, 2015, 00:00

  • Burden Of Symptomatic Copd Patients In Spain- Data From Continuing To Confront Copd International Patient Survey 2012-2013

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 18 Month Booster Dose of A Pertussis-Containing Vaccine on The Australian National Immunisation Program- A Dynamic Model-Based Analysis

    Nov 1, 2015, 00:00

  • Patients Experience At Hospital Discharge and Readmissions

    Nov 1, 2015, 00:00

  • Conflicts’ Mediation Between Consumers and Health Plans- The Usage Profile of The Available Channels for Complaints

    Nov 1, 2015, 00:00

  • Evaluacion De Costo-Utilidad Del Uso De Cetuximab Como Última Línea De Tratamiento Del Cáncer Colorrectal Metastásico

    Nov 1, 2015, 00:00

  • The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey- an Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Are Qalys An Appropriate Measure To Use When Evaluating Public Health Interventions In The Uk?

    Nov 1, 2015, 00:00

  • Direct Cost and Medication Usage Among Insured Type 2 Diabetes Patients with Chronic Kidney Disease under Hospitalization in Beijing and Tianjin, China

    Nov 1, 2015, 00:00

  • Delay Of Optimal Nocturia Treatment Is Costly- Results Of A Real World Survey Of Patients In Europe And The Usa

    Nov 1, 2015, 00:00

  • Search for Clinically and Economically Effective Lymphomas Treatment

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Cardio-Desfibrilador Implantable Comparado Con La Terapia Farmacológica Optima Para El Tratamiento De Los Pacientes Con Falla Cardiaca En Colombia

    Nov 1, 2015, 00:00

  • Higher Drug Survival Rates in Patients with Psoriasis Utilizing Etanercept Compared to Adalimumab – a Nationwide Population-Based Cohort Study in Sweden

    Nov 1, 2015, 00:00

  • Role Of Budget Impact Analysis In Market Access Of Biosimilars

    Nov 1, 2015, 00:00

  • Analysis of The Cost of Invasive Fungal Infections In Patients With Hemopoetic Stem Cell Transplantation

    Nov 1, 2015, 00:00

  • Practices of Substance Abuse and Risky Sexual Behavior Among Adama Science and Technology University Undergraduate Students in 2012/13 Academic Years

    Nov 1, 2015, 00:00

  • Pharmacovigilance in Oncology- Knowledge and Perception on Adverse Events Reporting in Brazil

    Nov 1, 2015, 00:00

  • Possible Applications of Real World Evidence in Safety Operations

    Nov 1, 2015, 00:00

  • Access to Biologics for Rheumatoid Arthritis in the Public Sector of a Latam Country

    Nov 1, 2015, 00:00

  • The Rheumatologist’s Perspective In Diagnostic Course and Management of Familial Mediterranean Fever

    Nov 1, 2015, 00:00

  • A Perspective on the use of Health Technology Assessment in Brazil and Mexico

    Nov 1, 2015, 00:00

  • Costo De Cáncer De Cuello Uterino En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Characterization of Osteoporosis In Portugal - Treatment Patterns And Reasons for Under-Treatment and Non-Persistence With Pharmacological Treatments

    Nov 1, 2015, 00:00

  • An Analysis Of Drivers Of Positive And Negative Appraisals By Nice’s Medical Technology Evaluation Programme (Mtep)

    Nov 1, 2015, 00:00

  • A Comprehensive Disease Model of Polycystic Ovary Syndrome (Pcos)

    Nov 1, 2015, 00:00

  • Observational (Obs), Pragmatic (Pra), And Indirect (Ind) Methodologies For Comparative Relative Effectiveness (Re) And Benefit-Risk (Br) Analyses

    Nov 1, 2015, 00:00

  • Does Out-Patient Medical Insurance Policy Work Among Ckd Patients In Non-Dialysis Phases? Evidence From Two Sample Cities In China

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Trastuzumab-Emtansine Para El Manejo De Pacientes Con Cáncer De Mama Her2 Positivo Avanzado Con Tratamiento Previo Con Trastuzumab Y Un Taxano Por Separado O En Combinación, Para Venezuela

    Nov 1, 2015, 00:00

  • Economic Modelling Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00

  • The Atlantic Divide In Coronary Heart Disease- Health Technologies Use In The Us And Portugal

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • Análisis Del Comportamiento De La Drepanocitosis En Colombia, Desde La Perspectiva Del Uso De Servicios De Salud

    Nov 1, 2015, 00:00

  • Resource And Cost Savings Due To Subcutaneous Versus Intravenous Administration Of Oncology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • New Drugs In Advanced Melanoma- Disparities In Requirements For Post-Launch Real-Word Evidence In Europe

    Nov 1, 2015, 00:00

  • Systematic Review Of Productivity Losses Associated With Cardiovascular Disease In Europe

    Nov 1, 2015, 00:00

  • Work Capacity And Health Status Test of Police Officers

    Nov 1, 2015, 00:00

  • Vedolizumab In Crohn’s Disease; A Budget Impact Model for A Novel Drug In A Recession Environment

    Nov 1, 2015, 00:00

  • Costo De Cáncer Gástrico Avanzado En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00

  • Societal and Non-Healthcare Costs Associated With Atypical Haemolytic Uraemic Syndrome In The Uk- Results of A Patient Survey

    Nov 1, 2015, 00:00

  • Streamlining The Access Decision Process For German Patients to Receive Reimbursed Treatments In Another European Union Member State

    Nov 1, 2015, 00:00

  • Economic Benefits Of Endometrial Radiofrequency Ablation Compared With Other Endometrial Ablation Techniques In Women With Menorrhagia- A Retrospective Analysis With German Health Claims Data

    Nov 1, 2015, 00:00

  • Increasing Transparency and the Patient Voice in HTA of New Medicines

    Nov 1, 2015, 00:00

  • Productivity Loss Costs Attributable to Obesity in Working Patients with Diabetes in the US

    Nov 1, 2015, 00:00

  • The Cost and Length of Stay of Hospital Emergency Department Visits for Chronic Heart Failure Patients in Canada

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Treatment Patients With Craniocerebral Injury In Ukraine

    Nov 1, 2015, 00:00

  • Assessing The Level Of Resistance/Intolerance To Hydroxyurea Therapy Amongst Patients With Polycythemia Vera In Europe

    Nov 1, 2015, 00:00

  • Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers- Patterns of Treatment and Costs

    Nov 1, 2015, 00:00

  • Economic Evaluations of Treatments for Inflammatory Bowel Diseases

    Nov 1, 2015, 00:00

  • The german nice or the german nasty? an analysis of iqwig decisions and requirements for an ‘added benefit'

    Nov 1, 2015, 00:00

  • PATIENT CHARACTERISTICS AND HEALTHCARE BURDEN OF CANCER HOSPITALIZATIONS IN THE UNITED STATES

    Nov 1, 2015, 00:00

  • Proton Pump Inhibitors In Italy- It’s Time to Make A (Policy) Change

    Nov 1, 2015, 00:00

  • Pharmacoeconomical Characteristics of Different Strategies of Hemostasis During Extensive Hepatectomy

    Nov 1, 2015, 00:00

  • Increased Costs Due To Myocardial Infarction (Mi) In Fran An Observational Analysis Using A Claims Database

    Nov 1, 2015, 00:00

  • Pharmacoepidemiologic Modeling of Treatment Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabin (Single Tablet Regimen) in Russia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan

    Nov 1, 2015, 00:00

  • Does use of calcium channel blockers affect the risk of incident active tuberculosis disease? A nested case control study on a national health claim database

    Nov 1, 2015, 00:00

  • A Novel Itc Approach- Matching Patient-Level Data To Study-Level Summary Means And Variances

    Nov 1, 2015, 00:00

  • Using Real-World Hospital Purchasing And Consumption Data To Improve Healthcare Systems Efficiencies

    Nov 1, 2015, 00:00

  • Disease Prevalence and Healthcare Resources Consumption in Patients with Basal Cell Carcinoma in Italian Lhus

    Nov 1, 2015, 00:00

  • The Epipen4schools® Survey- Staff Training And Use Of Epinephrine Auto-Injectors For The Treatment Of Anaphylaxis In Large Us School Districts

    Nov 1, 2015, 00:00

  • Patients’ Perception of Adherence to Therapy In Ulcerative Colitis- Results of A Survey to Specialized Centers

    Nov 1, 2015, 00:00

  • Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

    Nov 1, 2015, 00:00

  • Over-Prescription Of Fingolimod In Germany

    Nov 1, 2015, 00:00

  • Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Prostatectomy- a Comparison of Cost-Benefit Analysis Between Open Surgery and Robotic Techniques

    Nov 1, 2015, 00:00

  • The Most Profitable Health Insurance “Company” In Turkey

    Nov 1, 2015, 00:00

  • Inpatient Burden Among Patients With Cystic Fibrosis Who Are Homozygous for The F508del Mutation

    Nov 1, 2015, 00:00

  • Análisis De Costo Efectividad Del Uso De Sorafenib En Pacientes Con Carcinoma Hepatocelular En Estadios Avanzados, Para El Contexto Ecuatoriano

    Nov 1, 2015, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary In Case Of Erythropoietin Products

    Nov 1, 2015, 00:00

  • Safety And Insurance Premium Implications For Hospitals Based On Subcutaneous Versus Intravenous Administration Of Oncology / Hematology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • The Association of Waist Circumference and Microvascular Complications in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00

  • Systematic Literature Review And Critical Appraisal Of The Suitability Of The Outcome Measures Used In The Idiopathic Pulmonary Fibrosis

    Nov 1, 2015, 00:00

  • Do Payers Equally Value the Cost Per Month of Overall Survival for Metastatic Castration Resistant Prostate Cancer within the Eu5?

    Nov 1, 2015, 00:00

  • A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis- Compliant Vs. Non-Compliant Patients

    Nov 1, 2015, 00:00

  • Global Publication Trends in Medical Nutrition Health Economics

    Nov 1, 2015, 00:00

  • An Open Label, One Arm Study To Evaluate The Efficacy And Safety of Cerebrolysin In Patients With Acute Severe Ischemic Stroke In Mexico

    Nov 1, 2015, 00:00

  • Systematic Review Of Cost Effectiveness Of Ultra-Orphan Therapies

    Nov 1, 2015, 00:00

  • Accessing The Medical Devices Market In Egypt And Saudi Arabia- A Systematic Review Of Policies And Regulations

    Nov 1, 2015, 00:00

  • Reducing Insulin Syringe Reuse Can Help Lower Cost of Insulin Waste In Brazil

    Nov 1, 2015, 00:00

  • Cost Analysis in Implementing Rituximab for non-Hodgkins Lymphoma - Intravenously and Subcutaneously - in Patients with Social Coverage in Latam

    Nov 1, 2015, 00:00

  • Persistence to Therapy and the Associated Risk of Fractures with Antiosteoporotic Drugs

    Nov 1, 2015, 00:00

  • Healthcare Pathways And Burden of Disease of Patients With Inflammatory Bowel Diseases (Ibd)

    Nov 1, 2015, 00:00

  • A Retrospective, Cross Sectional Study on the Prevalence of Hypertension and Treatment Status in Obese Patients Using a Healthcare Database in Japan

    Nov 1, 2015, 00:00

  • Evaluaci”N De Costo-Efectividad De La Implementaci”N De Monitoreo Ambulatorio De Presi”N Arterial Versus Perfil De Presi”N Arterial Para El Diagn”Stico De Hipertensi”N En El Sistema Público Chileno

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of Aspirin In The Primary Prevention Of Cardiovascular Diseases And Colorectal Cancer

    Nov 1, 2015, 00:00

  • Systematic Review And Meta-Analysis of Efficacy And Safety of Simeprevir And Sofosbuvir For Hcv Genotype 1 Infection

    Nov 1, 2015, 00:00

  • From Phase Ii Studies to Hta Submissions- Optimal Use of Evidence for Informed Decisions

    Nov 1, 2015, 00:00

  • Construction Of Simulation Techniques For Development Of Optimal Cervical Cancer Screening Strategies- Experience Of Ukraine

    Nov 1, 2015, 00:00

  • Psychometric Validation of the Multidimensional Dyspnea Profile (Mdp) Questionnaire

    Nov 1, 2015, 00:00

  • Medical Devices For Bandaging And Plasters. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • Benefits And Risks of Vildagliptin/Metformin Versus Sulphonylureas/Metformin Combination Therapy In Type 2 Diabetes Mellitus (T2dm) From Patient’s Perspective- Real-World Data

    Nov 1, 2015, 00:00

  • Análise De Custo-Utilidade Em Pacientes Com Insuficiência Renal Crônica Submetidos À Terapia Renal Substitutiva (Trs)

    Nov 1, 2015, 00:00

  • Symptoms, Concomitant Conditions And Cardiac Risk In European Hydroxyurea Treated Polycythemia Vera Patients

    Nov 1, 2015, 00:00

  • Sq® Hdm Slit-Tablets In Addition To Pharmacotherapy Are Cost-Effective Compared To Pharmacotherapy Only In Treating Patients With Allergic Asthma

    Nov 1, 2015, 00:00

  • A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme

    Nov 1, 2015, 00:00

  • Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Neoplasm of Colon

    Nov 1, 2015, 00:00

  • Assesing The Net Fiscal Consequences Of Tobacco Use In A High Consumption And High Tobacco Tax Country- The Case Of Greece

    Nov 1, 2015, 00:00

  • The Impact of Anti-Tnf (Etanercept) Therapy on Work Productivity in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in the Czech Republic

    Nov 1, 2015, 00:00

  • Assocations Between Pain Severity and Quality of Life Domains Among Those Diagnosed With Various Pain Types In Europe

    Nov 1, 2015, 00:00

  • Migration of the Fatigue Symptoms and Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rmstm) from Paper to an Electronic Diary Format

    Nov 1, 2015, 00:00

  • The Economic Burden Of Cardiac Complications Of Percutaneous Coronary Intervention In England- An Analysis Of Hospital Episode Statistics

    Nov 1, 2015, 00:00

  • Tioropium+Olodaterol Respimat; Budget Impact In The Uk

    Nov 1, 2015, 00:00

  • In Greece, During 2009-2014, Public Pharmaceutical Expenditure Undoubtedly Fell; But On Whose Backs?

    Nov 1, 2015, 00:00

  • Reduction of Complications and Associated Costs for Type 2 Diabetic Patients Using Continuous Subcutaneous Insulin Infusion In The Uk

    Nov 1, 2015, 00:00

  • Economic Burden Outcomes In Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated With Non-Valvular Atrial Fibrillation In Italy

    Nov 1, 2015, 00:00

  • Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry- Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015

    Nov 1, 2015, 00:00

  • Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the ...

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Qualitative Equivalence Between Paper and Ediary Versions and Usability of 4 Pro Questionnaires for Uterine Fibroids

    Nov 1, 2015, 00:00

  • Monitoring Of Critical Laboratory Results To Improve Quality Of Patient Care In A Large Urban Clinic In Uganda

    Nov 1, 2015, 00:00

  • Patient Access Schemes Within The Uk- A Retrospective Analysis

    Nov 1, 2015, 00:00

  • Implante de Ahmed Versus Implante de Baerveldt- Una Revisión Sistemática y Meta-Análisis

    Nov 1, 2015, 00:00

  • Assessment of Hiv-Related Quality of Life in a Representative Sample Of French Patients using Multivariate Multi-Block Statistical Models

    Nov 1, 2015, 00:00

  • Treatment Continuation And Treatment Characteristics Of Four Long Acting Antipsychotic Medications (Paliperidone Palmitate, Risperidone Microspheres, Olanzapine Pamoate And Haloperidol Decanoate) In The Netherlands

    Nov 1, 2015, 00:00

  • Resource Utilisation And Bleeding Events During Anticoagulation Treatment- Real-World Findings From England

    Nov 1, 2015, 00:00

  • Efeitos da Atenção Farmacêutica nos Resultados em Saúde Dos Pacientes- Revisão Sistemática Com Meta-Análises

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management

    Nov 1, 2015, 00:00

  • Impact of Alexithymia and Disease Characteristics on Work Productivity and Activity In Psoriasis Patients With Short Disease Duration- Epidepso Multicentre Study

    Nov 1, 2015, 00:00

  • Descripttive Evaluation of Patient Characteristics and Health Care Resource utilization of Patients Diagonsed with Breast Cancer

    Nov 1, 2015, 00:00

  • Evolution Of Tiotropium Efficacy Vs. Placebo Over Time For The Maintenance Therapy Of Chronic Obstructive Pulmonary Disease- From Investigational Product To Active Reference

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of the Introduction of Routine Varicella Vaccination in Children in the United Kingdom

    Nov 1, 2015, 00:00

  • Evaluation of Average Cost-Effectiveness Ratios of Standards of Care Across Different Indications

    Nov 1, 2015, 00:00

  • Anticoagulant Treatment After Vte In The Netherlands

    Nov 1, 2015, 00:00

  • Patient Utility Estimates In Patients At High Cardiovascular Risk

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Impact Of Percutaneous Coronary Interventions On The Hospitalization Cost, Length Of Stay And Mortality Of Patients Hospitalized With Acute Coronary Syndromes

    Nov 1, 2015, 00:00

  • Tabagismo Em Universitários- Uma Revisão Sistemática Da Literatura

    Nov 1, 2015, 00:00

  • Prma Reform in Poland – Impact on Pharmaceutical Industry and Market Access

    Nov 1, 2015, 00:00

  • National Estimates of Prevalence and Patterns of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson’s Disease in Nursing Home and Home Healthcare Settings in the United States

    Nov 1, 2015, 00:00

  • Relationship between Spending on Diabetes Drugs and Occurrence of Risks Associated with Type 2 Diabetes in English General Practices

    Nov 1, 2015, 00:00

  • Malaria Diagnosis And Treatment Practice Following Introduction of Rapid Diagnostic Test In Selected Health Posts of Adama Woreda, East Shewa Zone, Oromia Region,Centeral Ethiopia

    Nov 1, 2015, 00:00

  • A Real-World Analysis Of Korean Nation-Wide Database- Pattern, Adherence, And Associated Heatlhcare Costs Of Imatinib Among Patients With Chronic Myeloid Leukemia

    Nov 1, 2015, 00:00

  • Differences And Similarities In Hta- A Comparative Analysis Of The Decision-Making Processes For Cancer Drugs Across 4 Countries

    Nov 1, 2015, 00:00

  • Risk Factors for Coronary Artery Disease In Patients With Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Clinical And Health-Economic Criteria for the Assessment of New Immune-Oncologic Drugs in Spain

    Nov 1, 2015, 00:00

  • Translation and Linguistic Validation of the Caregiver Quality of Life Cystic Fibrosis Scale (Cqolcf) and the Multidimensional Scale of Perceived Social Support (Mspss) for use in Germany and the United Kingdom (Uk)

    Nov 1, 2015, 00:00

  • Finding The Optimal Screening Program For Unknown Atrial Fibrillation Using Simulation Models

    Nov 1, 2015, 00:00

  • Systematic Review Of Cost Effectiveness Of Gefitinib In The Treatment Of Non-Small Cell Lung Cancer In China

    Nov 1, 2015, 00:00

  • Are Medicines Granted with a Conditional Approval by the European Medicines Agency Gaining Positive Assessment by Payers in France, Germany and the United Kingdom?

    Nov 1, 2015, 00:00

  • Opportunistic Screening For Atrial Fibrillation In Primary Care – A Clinical And Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) – First Step Towards a Pro Measure in Lpld

    Nov 1, 2015, 00:00

  • Public Health Outcomes of Paediatric Influenza Vaccination With An Intranasal Tetravalent Live Attenuated Vaccine In Belgium Using A Dynamic Transmission Model

    Nov 1, 2015, 00:00

  • Cost Analysis of Two Methods for Improving the Quality of Care (Qoc) Scores in Paediatric Hospital Wards During Winter Periods

    Nov 1, 2015, 00:00

  • Quality Analysis of Pharmacoeconomics Evaluation and Application Literature in China During 2009-2013

    Nov 1, 2015, 00:00

  • The End of the Exceptional Financing of Erythropoiesis-Stimulating Agents in French Hospitals- What are the Impacts For Public Hospitals of Paris ?

    Nov 1, 2015, 00:00

  • Statin Use and Risk of New-Onset Type 2 Diabetes Mellitus and Cardiovascular Disease- a Nationwide Population-Based Observational Study Using National Claim Data

    Nov 1, 2015, 00:00

  • Autosomal Polycystic Kidney Disease (Adpkd)- Costs And Resource Utilisation In The Nordic Countries

    Nov 1, 2015, 00:00

  • The Association Between Disease Activity And Indirect Costs of Absenteeism And Presenteeism Generated By Patients With Ankylosing Spondylitis In Polish Population

    Nov 1, 2015, 00:00

  • Prevalence of Self-Medication and Its Reason Among Pharmacy Students in India- A cross-sectional study

    Nov 1, 2015, 00:00

  • Cost-Effectivness Analysis of Shizophrenia Treatment With Haloperidol , Olanzapine And Risperidone In Bosnia and Hercegovina ,Republic of Srpska By Application of The Markov Model

    Nov 1, 2015, 00:00

  • Treatment Patterns And Budgetary Impact of Chemotherapy Drugs In A Brazilian Private Health Plan (Php)

    Nov 1, 2015, 00:00

  • A Cost-Utility Analysis Of Nab-Paclitaxel (Abraxane) Plus Gemcitabine In Metastatic Pancreatic Cancer In Slovak Republic

    Nov 1, 2015, 00:00

  • Analysis Of In-Hospital Resource Use After An Ischemic Stroke

    Nov 1, 2015, 00:00

  • Immunisation in Latin America- Factors Preventing Uptake of Cost-Effective Vaccines

    Nov 1, 2015, 00:00

  • Pricing and Reimbursement Policies of Turkey and Ukraine

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Phid-Cv Routine Vaccination Programme Compared To Pcv-13 In Portugal

    Nov 1, 2015, 00:00

  • High Therapeutic Efficiency With Ledipasvir/Sofosbuvir For The Treatment Of Genotype 1 Chronic Hepatitis C In Portugal

    Nov 1, 2015, 00:00

  • Drug Pricing Information Management- Development Of A Web Based E-Pricing System

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Trimetazidine In The Management Of Chronic Stable Angina In Greece

    Nov 1, 2015, 00:00

  • Conditional Agreements For Innovative Therapies In Italy- The Case Of Pirfenidone

    Nov 1, 2015, 00:00

  • The Conceptual Framework and Content Validity of the Polycystic Ovary Syndrome Patient Reported Outcome (Pcos-Pro) Scale

    Nov 1, 2015, 00:00

  • Burden of Disease of Ovarian Cancer in Spain. Ovarcost Study

    Nov 1, 2015, 00:00

  • Network Meta-Analysis of Various Treatment Strategies in Resistant Hypertension

    Nov 1, 2015, 00:00

  • The Budget Impact of Denosumab in the Treatment of Giant Cell Tumor of the Bone (Gctb) in Belgium

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Wh ...

    Nov 1, 2015, 00:00

  • Intra- And Extra-Organizational Factors Affecting Community Pharmacy Performance

    Nov 1, 2015, 00:00

  • Efficacy-Effectiveness-Gap – Extent, Causes And Implications

    Nov 1, 2015, 00:00

  • Value Judgment of Health Interventions From Different Perspectives- Arguments and Criteria

    Nov 1, 2015, 00:00

  • The Consequences Of Replacing The Fleischner Guidelines By A Software-Based Volume Doubling Time Technique- An Early-Stage Research

    Nov 1, 2015, 00:00

  • A Cost-Effective Enhanced Retrospective Observational Study Methodology to Capture Economic Burden Evidence in a Rare Disease Using Non-Tuberculous Mycobacteria Infection as a Model

    Nov 1, 2015, 00:00

  • Aspirin Versus Clopidogrel in Patients with Ischemic Stroke- a Cost and Effectiveness Comparison from Beijing Medical Insurance Database

    Nov 1, 2015, 00:00

  • Productivity Loss Due to Low Back Pain- Results from Swedish Registers

    Nov 1, 2015, 00:00

  • Impacto Orçamentário Do Everolimo, Sirolimo E Tacrolimo Para Imunossupressão Em Transplantados Cardíacos No Sistema Público De Saúde Do Brasil

    Nov 1, 2015, 00:00

  • Cost of Paediatric Vaccine Administration in the United Kingdom (UK)- a Time and Motion (TM) Study

    Nov 1, 2015, 00:00

  • Evolution of Treatment Paradigms In Metastatic Castrate-Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Are vaccines getting a fair deal? Health technology assessment of vaccines across europe

    Nov 1, 2015, 00:00

  • The Competition Between Drugstore And Primary Care And Treatment Choice Of Patients In The Context Of Essential Medicine Policy In Rural China

    Nov 1, 2015, 00:00

  • Risk of Fracture in Type 2 Diabetes Mellitus Patients- Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • An Analysis of Diabetic Medicine Utilization In Turkey

    Nov 1, 2015, 00:00

  • The Societal and Economic Impact of Cervical Cancer in Brazil

    Nov 1, 2015, 00:00

  • Analysis Of Costs For Diagnosis And Differential Diagnosis Of Patients With Possible Temporomandibular Disorders In Ukrane

    Nov 1, 2015, 00:00

  • Bone Pain And Bone Targeting Agent (Bta) Treatment Patterns In Patients With Bone Metastases (Bms) From Breast Cancer (Bc) In Real World Setting In Europe

    Nov 1, 2015, 00:00

  • Efficacy of The Mica Antibody for Transplant Patients

    Nov 1, 2015, 00:00

  • Analysis of Preeclampsia Prevention in Real Practice and the Need to Improve Information Support of Doctors in Ukraine

    Nov 1, 2015, 00:00

  • Effect of Educational Intervention on Osteoporosis Knowledge Among University Female Students in Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Identification Of Items For A Standardised Resource-Use Measure- Review Of Current Instruments

    Nov 1, 2015, 00:00

  • The Cost Of Nutrition Alternatives For Premature Infants In The Neonatal Intensive Care Unit In Russia

    Nov 1, 2015, 00:00

  • Critical Analysis of Pricing and Reimbursement Process on The Basis of New Indroduced Pharmacoeconomic Guidelines In Bulgaria

    Nov 1, 2015, 00:00

  • Prescription Patterns Of Drugs For Attention-Deficit/Hyperactivity Disorders In Japanese Children And Adolescents

    Nov 1, 2015, 00:00

  • Compliance With Allopurinol Among Hypertensive Patients With Gout Diagnosis and The Relationship to Onset of End-Stage Renal Disease

    Nov 1, 2015, 00:00

  • Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu)

    Nov 1, 2015, 00:00

  • Rapid Increase of Health Litigation As A Means of Market Access For Innovative Medicines In Colombia And The Potential Role Of Health Technology Assessment

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Plaque Psoriasis In The Italian Setting

    Nov 1, 2015, 00:00

  • Quantifying The Impact of Treatment on The Public Health Burden of Adpkd- A Uk Case Study Using The Adpkd Outcomes Model

    Nov 1, 2015, 00:00

  • Valuation of Patient Satisfaction With Pharmaceutical Care As A Tool For Increasing Quality Management In Community Pharmacy And Patient’s Quality Of Life

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Bariatric Surgery In Germany

    Nov 1, 2015, 00:00

  • Measurement Of Hope In Patients With Cancer

    Nov 1, 2015, 00:00

  • Economic Analysis of Outpatient Parenteral Antimicrobial Therapy (Opat)- A Systematic Review

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Incobotulinumtoxin-A With Flexible Treatment Intervals Compared to Onabotulinumtoxin-A In The Management of Blepharospasm And Cervical Dystonia

    Nov 1, 2015, 00:00

  • The Devil Is Not So Black As He Is Painted – The Future of Immunization In Poland

    Nov 1, 2015, 00:00

  • A Systematic Review Of Markov Models Evaluating Multi-Component Disease Management Programs

    Nov 1, 2015, 00:00

  • Total Annual Cost Associated with Best Supportive Care of Patients with Unresectable Advanced Non-Small-Cell Lung Cancer Under Real-World-Conditions in Relation to Results of International Studies

    Nov 1, 2015, 00:00

  • Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin

    Nov 1, 2015, 00:00

  • Early Benefit Assessment And Uptake Of Pharmaceutical Innovations – Experiences From Germany 2011 To 2014

    Nov 1, 2015, 00:00

  • Targeted Combination Regimes In Oncology Challenges for Pricing and Reimbursment In Switzerland- Analysis of The Implication and Operational Requirement For Implementation of An Indication Code

    Nov 1, 2015, 00:00

  • The 3-Arm Strategy for Readmission Prevention- Automated Predictive Modeling, Readmission Prevention Intervention, and Monitoring

    Nov 1, 2015, 00:00

  • Determinação do Impacto Orçamentário no Modelo de Pagamento de Medicamentos Em Uma Operadora de Planos de Saúde- Buscando Novas Estratégias Para Minimizar Os Custos

    Nov 1, 2015, 00:00

  • A Streamlined Approach to Ethics Review in Brazil

    Nov 1, 2015, 00:00

  • Pro Self-Assessment and Patient Retention in Major Depression Studies- Efficiency of a Direct-To-Patient Contact Approach

    Nov 1, 2015, 00:00

  • Burden of Heart Failure In Latin America- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • Building Intentions with The Theory of Planned Behaviour- A Qualitative Assessment of Salient Beliefs About Pharmacy Value Added Services in Malaysia

    Nov 1, 2015, 00:00

  • Character of Toxic Damage of Liver In Influences of Substances of Mediator to Fetal Cells on Hepatocytes In Acute Liver Failure

    Nov 1, 2015, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based on Real-Life Data From Poland’s Social Insurance Institution Database In 2013

    Nov 1, 2015, 00:00

  • Efficacy And Safety Profile Of Combined Targeted Therapy Against Egfr And Vegf In Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • Survey of the Hungarian Physiotherapists’ Migration and Career Changing Behaviour

    Nov 1, 2015, 00:00

  • Access To The Procedure Care of Colorectal Cancer In Brazilian Public Health System- Use Of Diagnosis Resources In São Paulo State

    Nov 1, 2015, 00:00

  • Contraception Patterns In Fran A Real-World Database Analysis

    Nov 1, 2015, 00:00

  • Are the Irish Slower than they Think? A Systematic Analysis of all Recent Ncpe Appraisals

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Implementing Tenders Between The Branded Infliximab And Its Biosimilars In The Public Hospitals of Paris

    Nov 1, 2015, 00:00

  • Availability Of Drugs Recommended By Global Initiative For Chronic Obstructive Lung Disease (Gold) For Ukrainian Patients With Copd

    Nov 1, 2015, 00:00

  • Comparative Analysis of The Reimbursement Landscape of Orphan Drugs on An International Level

    Nov 1, 2015, 00:00

  • The Influence Of The Revision Of The Medical Fee Schedule On National Hospital Organisation Hospitals In Japan

    Nov 1, 2015, 00:00

  • Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States

    Nov 1, 2015, 00:00

  • Interpreting Results from Bayesian Network Meta-Analyses (Nma)- A Guide for Non-Statisticians

    Nov 1, 2015, 00:00

  • A Pitcure of Private Health Insurance Policyholders in Italy

    Nov 1, 2015, 00:00

  • Purpose, Belief And Rate of Disclosure of Cam Use Among Diabetic Patients In Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Differences Between The Efficacy of Biosimilars and Originators - Analysis and Implications for The Cost-Effectiveness-Analysis From A Payers Perspective

    Nov 1, 2015, 00:00

  • Benefit-Risk of Vka for Atrial Fibrillation Before Doac- a Cohort Study in a Claims and Hospitalization Database

    Nov 1, 2015, 00:00

  • Association between Weight Change, Diabetes-Related Healthcare Costs, and HbA1c among Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Medical Cost Associated with Treatment and Follow-Up of Pantients with Head and Neck Cancer

    Nov 1, 2015, 00:00

  • Review and Comparison of Eq-5d-3l Valuation Studies

    Nov 1, 2015, 00:00

  • Estimation of The Relative Efficacy of Licensed Regimens for Genotype-1 Hcv Infection Using A Mixed Treatment Comparison

    Nov 1, 2015, 00:00

  • Patient Reported Outcome in Health Services Research- A Prospective Study of Orthopedic Surgery in Routine Care in Switzerland

    Nov 1, 2015, 00:00

  • The Challenges of Carrying out an Indirect Comparison with Single-Arm Studies

    Nov 1, 2015, 00:00

  • International Comparison of Internet Information Source in Breast Cancer

    Nov 1, 2015, 00:00

  • National Study to Assess The Costs of Patients With High Myopia With and Without Choroidal Neovascularisation

    Nov 1, 2015, 00:00

  • Quality Of Life In Patients With Kidney Cancer In Slovakia

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- A German Hospital Perspective

    Nov 1, 2015, 00:00

  • Real World Data- Biologic Treatment for Naive Patient in the Lazio Region

    Nov 1, 2015, 00:00

  • Quality of Life Issues Important to Patients with Haematological Malignancies

    Nov 1, 2015, 00:00

  • Orphan Drugs Assessment in Germany- A Comparison with Other International HTA Agencies

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Gefitinib as the First Line Treatment in Patients With Positive Egfr Mutation In Metastatic or Locally Advanced non-Small Cell

    Nov 1, 2015, 00:00

  • Assessment of Direct Cost for Treatment of Influenza and Ari for Outpatient In Ukraine

    Nov 1, 2015, 00:00

  • How Has The Smc Patient And Clinician Engagement (Pace) Process Been Used In Assessments Of End-Of-Life Medicines And Medicines To Treat Very Rare Conditions?

    Nov 1, 2015, 00:00

  • Building a Bridge Between Clinical Evidence Research and Patient Preference Research

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Adjunctive Anti-Epileptic Drug Trials In Patients With Primary Generalized Tonic-Clonic Seizures Illustrates Changes in Standard of Care Over 12-20 Years

    Nov 1, 2015, 00:00

  • Clinical And Economic Analysis Of Effectiveness Of Fondaparinux Sodium In The Treatment Of Acute Coronary Syndrome

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • Development Of A Patient-Reported Outcome (Pro) Assessment Of Core Non-Small Cell Lung Cancer (Nsclc) Symptoms

    Nov 1, 2015, 00:00

  • Opioid Addiction Treatment in the eu5- Market Access Levers for Emerging Brands Entering a Generic Market

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Evaluation Comparing Biosimilar Bemfola to Gonal-F for the Treatment of Infertility in an Italian Contest

    Nov 1, 2015, 00:00

  • Healthcare Costs In Psoriatic Arthritis Patients Newly Initiated on Apremilast or Biologic Therapies

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Central Retinal Vein Occlusion (Crvo) In Turkey- An Expert Panel Approach For Estimation of Costs

    Nov 1, 2015, 00:00

  • Drug Pricing Reform in China - An Analysis of Piloted Pricing Approaches in the Context of International Experience

    Nov 1, 2015, 00:00

  • The Economic Consequences Of The Use Of Antibiotics In Belgium

    Nov 1, 2015, 00:00

  • Evaluation Analysis of Smoking Population in Ulaanbaatar

    Nov 1, 2015, 00:00

  • Review Of The Current Status Of Ras Mutation Testing In Patients With Metastatic Colorectal Cancer (Mcrc)- Flash-Ras Study

    Nov 1, 2015, 00:00

  • The Association between Disease Activity and Quality of Life among Patients with Ankylosing Spondylitis in Polish Population

    Nov 1, 2015, 00:00

  • Cognitive Debriefing And Usability Assessment Of The Eortc Qlq-C30 And Qlq-Br23 As Presented On Tablet And Handheld Devices

    Nov 1, 2015, 00:00

  • Cost of Illness (Out of Pocket Costs Paid By Patient) for T.B in Quetta City, Pakistan

    Nov 1, 2015, 00:00

  • Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England- Comparison of A Markov and Discrete Event Simulation Model

    Nov 1, 2015, 00:00

  • Dispensing of Vitamin Products by Retail Pharmacies in South Africa

    Nov 1, 2015, 00:00

  • Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States

    Nov 1, 2015, 00:00

  • Characteristics and Outcomes of Patients with Dengue Viral Infection During The Hospitalization At Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Experts Consensus on The Future of Rare Diseases Care and Orphan Drugs Access In Spain- A Delphi Study

    Nov 1, 2015, 00:00

  • Current Process and Future Path for Health Economic Assessment of Pharmaceuticals in France

    Nov 1, 2015, 00:00

  • Bayesian Econometric Modelling Of Observational Data For Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Leptospirosis; A Zoonotic, Morbid and Fatal Disease- A Record Viewing Study

    Nov 1, 2015, 00:00

  • Management Of Sore Throat In Community Pharmacy In Fran A National Observational Study

    Nov 1, 2015, 00:00

  • The Rise of Orphan Drugs In Europe Vs The United States- Comparing Orphan Drug Designations Between The Ema And Fda

    Nov 1, 2015, 00:00

  • What Is Ce Marking? How Technologies Are Classified, And How To Navigate The System

    Nov 1, 2015, 00:00

  • Individual and Societal Burden of Non-Adherence to Antidepressants in Brazil

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Diabetic Macular Edema (Dme) In Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Cost Savings By The Use Of Bemiparin In The Treatment Of Patients With Venous Thromboembolism In Spain

    Nov 1, 2015, 00:00

  • Trends in Non-Submissions in the UK

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation Of The Use Of Trastuzumab For Subcutaneous Administration Compared To Intravenous Dosage Form In The Treatment Of Breast Cancer

    Nov 1, 2015, 00:00

  • Similarities and Differences In Orphan Drug Reimbursement In 16 European Countries

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland

    Nov 1, 2015, 00:00

  • A Review of Patient Registries in Heart Failure Across European Union-5 Countries

    Nov 1, 2015, 00:00

  • Exenatide Once Weekly Plus Metformin for the Treatment of Type 2 Diabetes Mellitus- A Network Meta-Analysis of Randomised Controlled Trials

    Nov 1, 2015, 00:00

  • Indirect Treatment Comparison (Itc) To Demonstrate The Utility Of Oncolitbank- An Oncology Literature Registry

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of The Use of Daclatasvir for The Treatment of Hepatitis C Virus (Hcv) Genotypes 3, In The Italian Setting

    Nov 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96 (current)
  • 97
  • 98
  • 99
  • 100
  • »